Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Neonatal bilirubin trajectory phenotypes and composite adverse outcomes: a two-database latent-class analysis (MIMIC-III and PIC)

Abstract

Total serum bilirubin (TSB) is measured routinely in neonates, but whether its trajectory over the first postnatal week adds prognostic value beyond a single measurement is unclear. In this preregistered two-database retrospective cohort study, we fitted latent-class trajectory models separately within each database (primary analysis) and on the pooled population (secondary analysis), including neonates admitted at < 28 days of age with at least three TSB measurements on postnatal days 0–7 (MIMIC-III, n = 2,951; PIC, n = 1,817). Site-specific models identified four classes in MIMIC-III and two in PIC; agreement with pooled classes was low (adjusted Rand index 0.23 and 0.25). High-risk classes were associated with the composite outcome of in-hospital death, necrotizing enterocolitis, or late-onset sepsis in both databases (MIMIC-III: OR 5.66 [95% CI 3.72–8.61] and 3.16 [2.10–4.77]; PIC: OR 2.13 [1.40–3.24]). Outcome drivers differed: MIMIC-III associations reflected necrotizing enterocolitis and late-onset sepsis, whereas the PIC association reflected death. In MIMIC-III, birth-weight adjustment substantially attenuated the associations (Class 4 3.05→1.16; Class 1 5.47→1.85), whereas in PIC, where birth weight was unavailable, admission-weight adjustment strengthened the Class 1 association (OR 2.45→3.81). The trajectory model did not exceed the peak TSB value in MIMIC-III (AUC 0.825 vs. 0.827) and performed poorly in PIC (AUC 0.582; corrected calibration slope 0.719), indicating failed external validation. The hour-specific Bhutani nomogram comparison was applied outside its validated ≥ 35-week population. Bilirubin trajectories largely mark underlying immaturity and illness severity rather than a bilirubin-specific effect; these hypothesis-generating findings require prospective validation, particularly in infants born at ≥ 35 weeks.

Related

  1. Gestational age and antenatal growth discordance are principal predictors of composite neonatal outcomes in very preterm twins
    Lubomír Hašlík, Peter Korček, Petra Hanulíková +5
    Scientific ReportsPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  2. Multiple Organ Dysfunction Trajectory Phenotypes After Severe Trauma Are Associated With Distinct Immune Profiles and Outcomes
    H. Ding, M. Cox, Q. Qiu +7
    medRxivPreprintCC BY-NC-NDFull textEpidemiology & public healthmedRxivPMC
  3. Bilirubin metabolism-related genetic variants in neonatal hyperbilirubinemia: a multicenter case-control study in northern China
    Sihan Sheng, Ying Li, Lijuan Ma +8
    Frontiers in pediatricsPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  4. Development and Validation of Temperature Trajectory-Based Phenotypes in Pediatric Sepsis: A Multicenter Retrospective Cohort Study, 2012–2018
    Stephanie R. Brown, L. Nelson Sanchez-Pinto, Jocelyn R. Grunwell +10
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care SocietiesPeer-reviewedLicence not statedFull text1 citedGeneral medicinePMC
  5. Heart Failure Phenotypes and Trajectory by Gender Identity in a National Veteran Cohort
    Ian K. Everitt, MD, MPH, Meredith S. Duncan, PhD, Kory R. Heier, MS +7
    JACC: AdvancesPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineDOAJPMC
BibTeX
@article{lu2026neonatal,
  title = {{Neonatal bilirubin trajectory phenotypes and composite adverse outcomes: a two-database latent-class analysis (MIMIC-III and PIC)}},
  author = {Jingchuan Lu and Meiding Wang and Haiyi Xu and Shuangyan Zhu},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-76725-0},
  url = {https://www.nature.com/articles/s41598-026-76725-0},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Neonatal bilirubin trajectory phenotypes and composite adverse outcomes: a two-database latent-class analysis (MIMIC-III and PIC)
AU  - Jingchuan Lu
AU  - Meiding Wang
AU  - Haiyi Xu
AU  - Shuangyan Zhu
PY  - 2026
DA  - 2026/10/25
JO  - Scientific Reports
DO  - 10.1038/s41598-026-76725-0
UR  - https://www.nature.com/articles/s41598-026-76725-0
AB  - Total serum bilirubin (TSB) is measured routinely in neonates, but whether its trajectory over the first postnatal week adds prognostic value beyond a single measurement is unclear. In this preregistered two-database retrospective cohort study, we fitted latent-class trajectory models separately within each database (primary analysis) and on the pooled population (secondary analysis), including neonates admitted at < 28 days of age with at least three TSB measurements on postnatal days 0–7 (MIMIC-III, n = 2,951; PIC, n = 1,817). Site-specific models identified four classes in MIMIC-III and two in PIC; agreement with pooled classes was low (adjusted Rand index 0.23 and 0.25). High-risk classes were associated with the composite outcome of in-hospital death, necrotizing enterocolitis, or late-onset sepsis in both databases (MIMIC-III: OR 5.66 [95% CI 3.72–8.61] and 3.16 [2.10–4.77]; PIC: OR 2.13 [1.40–3.24]). Outcome drivers differed: MIMIC-III associations reflected necrotizing enterocolitis and late-onset sepsis, whereas the PIC association reflected death. In MIMIC-III, birth-weight adjustment substantially attenuated the associations (Class 4 3.05→1.16; Class 1 5.47→1.85), whereas in PIC, where birth weight was unavailable, admission-weight adjustment strengthened the Class 1 association (OR 2.45→3.81). The trajectory model did not exceed the peak TSB value in MIMIC-III (AUC 0.825 vs. 0.827) and performed poorly in PIC (AUC 0.582; corrected calibration slope 0.719), indicating failed external validation. The hour-specific Bhutani nomogram comparison was applied outside its validated ≥ 35-week population. Bilirubin trajectories largely mark underlying immaturity and illness severity rather than a bilirubin-specific effect; these hypothesis-generating findings require prospective validation, particularly in infants born at ≥ 35 weeks.
SN  - 2045-2322
ER  -